Diane Russell
Nurse Practitioner · Salt Lake City, UTNPI 1457994089
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$677
- Johnson & Johnson$597
- Amgen$369
- Boehringer Ingelheim$321
- Novartis$305
- Boston Scientific$296
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,241100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 42 | $677 |
| Johnson & Johnson | 36 | $597 |
| Amgen | 19 | $369 |
| Boehringer Ingelheim | 18 | $321 |
| Novartis | 14 | $305 |
| Boston Scientific | 17 | $296 |
| Pfizer | 15 | $265 |
| Merck | 14 | $243 |
| Actelion Pharmaceuticals US, Inc. | 18 | $233 |
| Chiesi USA, Inc. | 7 | $154 |
| Kiniksa Pharmaceuticals, Ltd. | 5 | $114 |
| Lexicon Pharmaceuticals, Inc. | 4 | $97 |
| Abbott | 4 | $87 |
| Amarin Pharma, Inc. | 5 | $76 |
| Philips North America LLC | 3 | $70 |
| Bayer | 3 | $52 |
| Daiichi Sankyo Inc. | 3 | $48 |
| Scpharmaceuticals Inc. | 2 | $41 |
| AstraZeneca | 3 | $39 |
| Heartflow, Inc. | 1 | $28 |
| Cvrx, Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Recor Medical Inc | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
| Abiomed | 1 | $10 |
How this compares
$4,241 in reported general payments places this provider in the 90th percentile of 979 nurse practitioner providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 42 | $46,907 |
| EliquisApixaban | 44 | $34,741 |
| EntrestoSacubitril/Valsartan | 23 | $22,289 |
| BrilintaTicagrelor | 51 | $22,077 |
| Ranolazine ErRanolazine | 16 | $1,648 |
| ClopidogrelClopidogrel Bisulfate | 109 | $1,296 |
| Atorvastatin Calcium | 102 | $1,114 |
| Flecainide Acetate | 24 | $701 |
| Midodrine Hcl | 11 | $612 |
| Metoprolol Succinate | 34 | $461 |
| Carvedilol | 51 | $447 |
| Bisoprolol Fumarate | 15 | $429 |
| Losartan Potassium | 42 | $424 |
| Rosuvastatin Calcium | 50 | $382 |
| Potassium Chloride | 27 | $362 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Brilinta | $39 | $68,98493 claims |
| PfizerEliquis | $265 | $34,74144 claims |
| NovartisEntresto | $305 | $22,28923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 979 nurse practitioner providers in Utah.
Other nurse practitioner in Salt Lake City
- Julia BattenSalt Lake City$223K
- Merin KinikiniSalt Lake City$19K
- Phillip BowmanSalt Lake City$13K
- Dana ShawSalt Lake City$10K
- Samantha AbertonSalt Lake City$10K
- Jennifer BushSalt Lake City$7K
- Stacy ParrySalt Lake City$6K
- Krystal BischoffSalt Lake City$5K
- Jennifer UrchSalt Lake City$5K
- Millie DorseySalt Lake City$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.